CUSIP 75383L102COMRAPPQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
142 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Trv Gp V, LLC | 7.14M | $216.48M | 0 | Held |
| 2 | Fmr LLC | 7.11M | $215.77M | +194.9K | Added |
| 3 | Arch Venture Management, LLC | 3.73M | $113.13M | 0 | Held |
| 4 | Capital International Investors | 3.40M | $103.23M |
| 0 |
| Held |
| 5 | Cormorant Asset Management, LP | 3.03M | $91.85M | −165.0K | Reduced |
| 6 | Goldman Sachs Group Inc | 3.00M | $91.08M | +579.9K | Added |
| 7 | Blackrock, Inc. | 2.43M | $73.78M | +863.8K | Added |
| 8 | Sofinnova Investments, Inc. | 1.90M | $57.78M | −43.2K | Reduced |
| 9 | Vanguard Group Inc | 1.82M | $55.15M | +191.2K | Added |
| 10 | Johnson & Johnson | 1.78M | $54.14M | 0 | Held |
See every fund holding Rapport Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders